Clinical Trials Directory

Trials / Unknown

UnknownNCT04738370

Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

To further develop the patient care pathway for women classified with a pregnancy of unknown location (PUL) and ectopic pregnancy (EP).

Detailed description

Purpose and design-There is a need for the patient care pathway to evolve in order to aid and improve the diagnosis and management of women with a pregnancy of unknown location (PUL) and ectopic pregnancy (EP). There is potential for this to be achieved by the incorporation of a statistical model that uses one or more novel markers identified by this study. Recruitment-1000 patients. Inclusion: Patients attending the Early Pregnancy Unit (EPU) in the first trimester with a PUL or ectopic pregnancy on trans-vaginal ultrasound scan between the ages of 18-50 years. Exclusion: Patients diagnosed with cancer, presence of acute medical condition, patients aged less than 18 years, patients who cannot give fully informed study consent. Consent - Posters will advertise the study. Patients in EPU will be invited to the study by a member of the clinical care team. Written consent will be required. Confidentiality - The Chief Investigator will preserve the confidentiality of participants taking part in the study and is registered under the Data Protection Act. Patient consent forms will be stored securely within the study file. All patient identifiable information, where required, will be stored electronically on National Health Service (NHS) approved computers, accessible only by personnel involved in the study via password. Conflict of interest - None involved in the study have a conflict of interest. Dissemination of results - No patient identifiable information will be included in the research report or publication. Anonymised results will be disseminated to scientific community by means of publication in peer-reviewed literature and presented at national and international meetings.

Conditions

Interventions

TypeNameDescription
OTHERSample collectionBloods +/- urine +/- vaginal swabs taken

Timeline

Start date
2014-12-08
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2021-02-04
Last updated
2022-04-01

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04738370. Inclusion in this directory is not an endorsement.